Literature DB >> 26702688

Cardiac amyloidosis presenting as recurrent acute coronary syndrome with unobstructed coronary arteries: Case report.

Anish George1, Brian McClements2.   

Abstract

Amyloidosis is a systemic disorder characterized by the deposition of mis-folded protein molecules within various organs. Cardiac involvement may be the presenting feature of this condition or may be identified incidentally during investigation for amyloidosis affecting other organs. The presence and severity of cardiac involvement varies with the type of amyloidosis. Irrespective of the subtype, patients with cardiac amyloidosis usually present with symptoms of heart failure with echocardiography showing features of restrictive cardiomyopathy. The usual cardiac symptoms noted in patients with amyloidosis include dyspnea, peripheral edema, and palpitations secondary to arrhythmias.(1) Chest pain secondary to myocardial ischemia is an unusual presentation of cardiac amyloidosis, and is attributed to the deposition of protein molecules in the coronary microvasculature. We describe the case of a patient who presented with recurrent cardiac ischemia secondary to amyloidosis.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Acute coronary syndrome; Cardiac amyloidosis; Cardiomyopathy; Intramural coronary infiltration

Mesh:

Year:  2015        PMID: 26702688      PMCID: PMC4699974          DOI: 10.1016/j.ihj.2015.08.029

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  16 in total

1.  Antibody-mediated resolution of light chain-associated amyloid deposits.

Authors:  R Hrncic; J Wall; D A Wolfenbarger; C L Murphy; M Schell; D T Weiss; A Solomon
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

3.  Cardiac amyloidosis.

Authors:  C Cristina Quarta; Jenna L Kruger; Rodney H Falk
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

4.  Systemic light chain amyloidosis: an update for treating physicians.

Authors:  Giampaolo Merlini; Ashutosh D Wechalekar; Giovanni Palladini
Journal:  Blood       Date:  2013-05-13       Impact factor: 22.113

Review 5.  Cardiac amyloidosis: where are we today?

Authors:  K S Patel; P N Hawkins
Journal:  J Intern Med       Date:  2015-06-16       Impact factor: 8.989

6.  Solid organ transplantation in AL amyloidosis.

Authors:  P T Sattianayagam; S D J Gibbs; J H Pinney; A D Wechalekar; H J Lachmann; C J Whelan; J A Gilbertson; P N Hawkins; J D Gillmore
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

7.  Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.

Authors:  John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

8.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

9.  Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.

Authors:  Joseph R Mikhael; Steven R Schuster; Victor H Jimenez-Zepeda; Nancy Bello; Jacy Spong; Craig B Reeder; A Keith Stewart; P Leif Bergsagel; Rafael Fonseca
Journal:  Blood       Date:  2012-02-13       Impact factor: 22.113

10.  Radiologic findings in renal amyloidosis.

Authors:  L Ekelund
Journal:  AJR Am J Roentgenol       Date:  1977-11       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.